Updated: FDA calls for noninferiority trials for antibacterials, thanks to new drugs for resistant infections
The FDA on Monday said it updated its recommendations for the clinical development of new antibacterial drugs, and thanks to a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
